Wright Medical Group N.V. to Present at the Jefferies Autumn 2015 Global Healthcare Conference
Thursday, November 19, 2015 at 10:40 a.m. GMT / 5:40 a.m. Eastern Time
Get Alerts WMGI Hot Sheet
Join SI Premium – FREE
AMSTERDAM, The Netherlands, Nov. 02, 2015 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) announced today that it will present at the Jefferies Autumn 2015 Global Healthcare Conference on Thursday, November 19, 2015, at The May Fair Hotel in London, UK. Julie Tracy, chief communications officer, will present at 10:40 a.m. GMT.
A live audio webcast of the conference presentation, along with the accompanying presentation materials, will be available on Wright’s corporate website at www.wright.com, under the “Investor Relations” link. The audio webcast and accompanying presentation materials will be archived on this site under the “Investor Presentations” link following the conference.
Internet Posting of Information
Wright routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.wright.com. The company encourages investors and potential investors to consult our website regularly for important information about us.
About Wright
Wright Medical Group N.V. is a global medical device company focused on Extremities and Biologics. The company is committed to delivering innovative, value-added solutions improving quality of life for patients worldwide and is a recognized leader of surgical solutions for the upper extremity (shoulder, elbow, wrist and hand), lower extremity (foot and ankle) and biologics markets, three of the fastest growing segments in orthopedics. For more information about Wright, visit www.wright.com.
Investors & Media: Wright Medical Group N.V. Julie D. Tracy Chief Communications Officer (901) 290-5817 (office) [email protected]Source: Wright Medical Group N.V.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
- Voya Increases Distribution Rate on 5 Funds
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!